BMO Capital Downgrades HCA Holdings (HCA) to Underperform

July 6, 2022 6:19 AM EDT
Get Alerts HCA Hot Sheet
Price: $215.03 -0%

Rating Summary:
    26 Buy, 5 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 8 | Down: 17 | New: 12
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

BMO Capital analyst Matt Borsch downgraded HCA Holdings (NYSE: HCA) from Market Perform to Underperform with a price target of $160.00 (from $233.00).

The analyst comments "We downgrade hospital company HCA to Underperform from Market Perform given simultaneous pressures on the top and bottom lines that combine to reduce earnings growth this year (and probably next) and to a greater degree than currently implied in stock prices. Our action follows last week's warning of lower 2Q/FY2022 earnings by UHS and the earlier tepid 1Q results from HCA. Accordingly, we cut our three-year fwd. revenue/earnings forecasts below current Street consensus. While our model implies modest improvement after 2022, we think risk is biased to the downside."

For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.

Shares of HCA Holdings closed at $172.58 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Downgrades, Hot Comments, Hot Downgrades

Related Entities

BMO Capital, Earnings